@@ -77,7 +77,6 @@ <h3>Structure of a B cell receptor</h3>
77
77
< h3 > Origins of B cell receptor diversity</ h3 >
78
78
< p > VDJ recombination
79
79
< p > Affinity maturation
80
-
81
80
</ section >
82
81
83
82
< section >
@@ -134,6 +133,16 @@ <h3>Dynamics in one GC</h3>
134
133
</ div >
135
134
</ section >
136
135
136
+ < section >
137
+ < h3 > Ab feedback may diversify the repertoire</ h3 >
138
+ < img class ="stretch " src ="images/em_div.png ">
139
+ < div class ="citation ">
140
+ < a href ="http://cobeylab.uchicago.edu/publications ">
141
+ Childs et al. 2015
142
+ </ a >
143
+ </ div >
144
+ </ section >
145
+
137
146
< section >
138
147
< h3 > GC B cells evolve</ h3 >
139
148
< img class ="stretch " src ="images/gc_micro.png ">
@@ -176,7 +185,7 @@ <h3>GCs produce plasma and memory cells</h3>
176
185
</ section >
177
186
178
187
< section >
179
- < h3 > Memory cells can evolve further</ h3 >
188
+ < h3 > (Can?) Memory cells evolve further (?) </ h3 >
180
189
< img src ="images/andrews_memory.jpg " style ="width: 70%; height: 70%; ">
181
190
< div class ="citation ">
182
191
< a href ="http://stm.sciencemag.org/content/7/316/316ra192 ">
@@ -185,17 +194,6 @@ <h3>Memory cells can evolve further</h3>
185
194
</ div >
186
195
</ section >
187
196
188
-
189
- < section >
190
- < h3 > Ab feedback may diversify the repertoire</ h3 >
191
- < img class ="stretch " src ="images/em_div.png ">
192
- < div class ="citation ">
193
- < a href ="http://cobeylab.uchicago.edu/publications ">
194
- Childs et al. 2015
195
- </ a >
196
- </ div >
197
- </ section >
198
-
199
197
< section >
200
198
< h3 > Clones can be long-lived</ h3 >
201
199
< img class ="stretch " src ="images/ch103.png ">
@@ -227,9 +225,9 @@ <h3>Broadly neutralizing antibodies to flu elusive</h3>
227
225
</ section >
228
226
229
227
< section data-background ="#99CCFF ">
230
- < p > Why do some people develop broadly neutralizing antibodies? </ p >
231
- < p > Can we induce them in everyone?
232
- < p > Will they dominate?
228
+ < p > Why do some people develop more bnAbs?
229
+ < p > Can we induce high levels in everyone?
230
+ < p > How can we guarantee they will dominate?
233
231
</ section >
234
232
235
233
< section >
@@ -371,6 +369,7 @@ <h3>Early infections affect vaccine response</h3>
371
369
</ a >
372
370
</ div >
373
371
</ section >
372
+
374
373
375
374
< section >
376
375
< h3 > Response to 2009 H1N1 vaccine</ h3 >
@@ -413,15 +412,15 @@ <h3>Stalk antibodies are more polyreactive</h3>
413
412
</ section >
414
413
415
414
< section data-background ="#99CCFF ">
416
- < h3 > Potential factors influencing specific antibody responses </ h3 >
415
+ < h3 > What determines Ab immunodominance? </ h3 >
417
416
< p > Host genotype
418
417
< p > Order (Age?) of infection
419
418
< p > Immunogenicity
420
419
< p > Autoreactivity
421
420
</ section >
422
421
423
422
< section >
424
- < h3 > In U.S., flu vaccine coverage is high</ h3 >
423
+ < h3 > In U.S., flu vaccine coverage is high(-ish) </ h3 >
425
424
< img src ="images/vaccine_coverage.png " style ="width: 60%; height: 60%; ">
426
425
< div class ="citation ">
427
426
< a href ="https://www.cdc.gov/flu/fluvaxview/coverage-1516estimates.htm ">
@@ -431,7 +430,7 @@ <h3>In U.S., flu vaccine coverage is high</h3>
431
430
</ section >
432
431
433
432
< section >
434
- < h3 > In RCT, vaccine provides high indirect protection</ h3 >
433
+ < h3 > In RCT, vaccine provides indirect protection</ h3 >
435
434
< img src ="images/hutterite.png " style ="width: 90%; height: 90%; ">
436
435
< div class ="citation ">
437
436
< a href ="http://jamanetwork.com/journals/jama/fullarticle/185509 ">
@@ -471,6 +470,16 @@ <h3>Sin diminishes egg effects in 2012-2013?</h3>
471
470
</ div >
472
471
</ section >
473
472
473
+ < section >
474
+ < h3 > Vaccine effectiveness tracks cohorts</ h3 >
475
+ < img src ="images/cohort_ve.png " style ="width: 60%; height: 60%; ">
476
+ < div class ="citation ">
477
+ < a href ="https://www.medrxiv.org/content/10.1101/19001875v1 ">
478
+ Arevalo et al. 2019
479
+ </ a >
480
+ </ div >
481
+ </ section >
482
+
474
483
< section >
475
484
< h3 > Another curiosity: low VE in repeat vaccinees</ h3 >
476
485
< img src ="images/mclean.jpg " style ="width: 90%; height: 90%; ">
0 commit comments